Corcept Therapeutics, Inc. (CORT) Posts Narrower than Expected Q2 Loss of 9c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $113.76 +3.15%
EPS Growth %: +406.3%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +406.3%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Raymond James Reiterates Underperform Rating on Lennar (LEN)
- BMO Capital Reiterates Market Perform Rating on Axalta Coating Systems (AXTA)
Create E-mail Alert Related Categories
Earnings, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
